DOYLE WILLIAM F bought NVCR
March 3, 2026 · Form 4 insider transaction
DOYLE WILLIAM F bought 258,445 shares of NovoCure Limited at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
258,445
Price
$0.00
Total value
N/A
InsiderDOYLE WILLIAM F
RoleOfficer, Director
CompanyNovoCure Limited (NVCR)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 3, 2026
Filing dateMarch 5, 2026
Shares owned after258,445
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Options to buy ordinary shares that are scheduled to vest in equal parts on the first, second, third and fourth anniversary of the grant date, subject to the reporting person's continued employment through such date.